These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2470074)

  • 1. Agonist-induced substance P receptor down-regulation in rat central nervous system.
    Inoue A; Takeda R; Fukuyasu T; Nakata Y; Segawa T
    Pharm Res; 1988 Dec; 5(12):795-9. PubMed ID: 2470074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent molecular weight of the substance P binding site in rat brain.
    Nakata Y; Hiraoka C; Segawa T
    Eur J Pharmacol; 1988 Jul; 152(1-2):171-4. PubMed ID: 2463172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine reduces substance P binding in rat spinal cord membrane preparation.
    Hama AT; Nakata Y; Segawa T
    Jpn J Pharmacol; 1991 Jan; 55(1):157-60. PubMed ID: 1710300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of 3H-substance P binding sites in rat brain membranes.
    Park CH; Massari VJ; Quirion R; Tizabi Y; Shults CW; O'Donohue TL
    Peptides; 1984; 5(4):833-6. PubMed ID: 6208537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and long-term treatment with methamphetamine on substance P concentration and receptor numbers in the rat brain.
    Ujike H; Ogawa N; Otsuki S
    Brain Res; 1988 Jun; 453(1-2):136-42. PubMed ID: 2456832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system.
    Shults CW; Quirion R; Chronwall B; Chase TN; O'Donohue TL
    Peptides; 1984; 5(6):1097-128. PubMed ID: 6085163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic distribution of brain neurokinin-1/substance P receptors using a highly selective ligand [3H]-[Sar9,Met(O2)11]-substance P.
    Dam TV; Martinelli B; Quirion R
    Brain Res; 1990 Oct; 531(1-2):333-7. PubMed ID: 1705154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.
    Ploux O; Lavielle S; Chassaing G; Julien S; Marquet A; d'Orléans-Juste P; Dion S; Regoli D; Beaujouan JC; Bergström L
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8095-9. PubMed ID: 2446317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
    Fardin V; Garret C
    Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
    Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
    J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.
    Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E
    Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
    Helke CJ; Phillips ET; O'Neill JT
    J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of desensitization to neurokinin A due to partial agonist property of this peptide at parotid substance P receptors.
    McMillian MK; Talamo BR
    Brain Res; 1989 Feb; 480(1-2):330-4. PubMed ID: 2469516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two modes of regulation of the phospholipase C-linked substance-P receptor in rat parotid acinar cells.
    Sugiya H; Obie JF; Putney JW
    Biochem J; 1988 Jul; 253(2):459-66. PubMed ID: 2460079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
    Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developmental influence of substance P on its receptors.
    Handelmann GE; Shults CW; O'Donohue TL
    Int J Dev Neurosci; 1987; 5(1):11-5. PubMed ID: 2459902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.
    Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Chassaing G; Lavielle S; Besseyre J; Garret C; Carruette A; Glowinski J
    J Neurochem; 1991 Mar; 56(3):879-89. PubMed ID: 1704425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The substance P receptor subtype modulating catecholamine release from adrenal chromaffin cells.
    Boksa P; Livett BG
    Brain Res; 1985 Apr; 332(1):29-38. PubMed ID: 2581649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.